Sudden Development of Subcutaneous Nodules Shortly after Radioiodine Treatment for Thyroid Cancer Caused by Self-Limiting Sarcoidosis

  • Wael Zaher Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium
  • Sammy Place Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium
  • Yannick Gombeir Department of Internal Medicine, EpiCURA Hospital, Hornu, Belgium

Keywords

Sarcoidosis, radioiodine therapy, thyroid cancer

Abstract

Case presentation: A 50-year-old female presented with an onset of multiple subcutaneous nodules on her 4 limbs. These nodules appeared concomitantly with the initiation of radioactive iodine therapy for papillary thyroid cancer. These nodules were not obvious on inspection of the skin, but easily felt on palpation.
The biopsy of the subcutaneous nodules revealed hypodermic non-caseating granulomas consistent with sarcoidosis. The patient underwent an 18F-fluorodeoxyglucose positron emission tomography (PET) scan study that revealed, besides the subcutaneous nodules, multiple hypermetabolic mediastinal lymphadenopathies and cervical adenopathies. Biopsy of the mediastinal lymphadenopathy showed neither granulomas nor neoplastic cells. Cervical biopsy revealed neoplastic cells of thyroid origin. Laboratory tests were normal. Bronchoalveolar lavage showed a normal CD4/CD8 T-cell ratio.
A diagnosis of cutaneous sarcoidosis was established, as well as a recurrence of the cancerous disease. The subcutaneous nodules regressed spontaneously in the absence of any treatment.
Discussion and conclusion: Sarcoidosis is a multisystemic disease of unknown origin. This case illustrates an uncommon occurrence of sarcoidosis, triggered by radioactive iodine therapy. Radioiodine may lead to immunological changes, especially affecting the Th1/Th2 ratio, which may promote the emergence of sarcoidosis in genetically predisposed patients. There is still much to discover to fully understand the pathogenesis of sarcoidosis.

VIEW THE ENTIRE ARTICLE

References

  • Vainsencher D, Winkelmann RK. Subcutaneous sarcoidosis. Arch Dermatol 1984;120:1028–1031.

  • Marcoval J, Moreno A, Mañá J, Peyri J. Subcutaneous sarcoidosis. Dermatologic Clinics 2008;26(4):553–556.

  • Broos CE, Hendriks RW, Kool M. T-cell immunology in sarcoidosis: disruption of a delicate balance between helper and regulatory T-cells. Curr Opin Pulm Med2016;22(5):476–483.

  • Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA 2011;305(4):391–399.

  • Loke WS, Herbert C, Thomas PS. Sarcoidosis: immunopathogenesis and immunological markers. Int J Chronic Dis 2013;2013:928601.

  • Simonovic SZ, Mihaljevic O, Majstorovic I, Djurdjevic P, Kostic I, Djordjevic OM, et al. Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer: elevated Th2/Th9 cytokine production before and reduced Th2 cytokine production after radioactive iodine therapy. Cancer Immunol Immunother 2015;64(1):75–82.

  • Xiang GA, Chen KY, Wang HN, Xiao JF. Immunological influence of iodine-125 implantation in patients with hepatocellular carcinoma resection. Nan Fang Yi Ke Da Xue Xue Bao 2010;30(2):292–294.

  • Myint ZW, Chow RD. Sarcoidosis mimicking metastatic thyroid cancer following radioactive iodine therapy. J Community Hosp Intern Med Perspect 2015;5(1):26360.
  • Published: 2020-05-11

    Issue: Vol 7 No 8 (view)

    Section: Articles

    How to cite:
    1.
    Zaher W, Place S, Gombeir Y. Sudden Development of Subcutaneous Nodules Shortly after Radioiodine Treatment for Thyroid Cancer Caused by Self-Limiting Sarcoidosis. EJCRIM [Internet]. 2020May11 [cited 2020Sep.24];7(8). Available from: https://ejcrim.com/index.php/EJCRIM/article/view/1621